Eton Pharmaceuticals, Inc.ETONNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | 18.65% |
| Q2 2025 | 9.52% |
| Q1 2025 | 48.38% |
| Q4 2024 | 12.81% |
| Q3 2024 | 13.78% |
| Q2 2024 | 13.91% |
| Q1 2024 | 8.93% |
| Q4 2023 | 4.06% |
| Q3 2023 | -41.42% |
| Q2 2023 | 126.19% |
| Q1 2023 | -37.59% |
| Q4 2022 | 164.00% |
| Q3 2022 | -56.25% |
| Q2 2022 | 238.14% |
| Q1 2022 | -64.29% |
| Q4 2021 | 686.19% |
| Q3 2021 | -74.73% |
| Q2 2021 | -74.22% |
| Q1 2021 | 14587.65% |
| Q4 2020 | 150.31% |
| Q3 2020 | -905.00% |
| Q2 2020 | -79.80% |
| Q1 2020 | -78.43% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | -100.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |